Gainers On Major News: The Walt Disney Company (NYSE:DIS), Netflix, Inc. (NASDAQ:NFLX), Alibaba Group Holding Ltd (NYSE:BABA), Tesla Motors (NASDAQ:TSLA), Baxalta (NYSE:BXLT)

Disney Company (NYSE:DIS) posted record profit in the June quarter, but its revenue missed Wall Street expectations for the first time in two years. It had net income of $2.48 billion, up 11 per cent from a year earlier, and revenue of $13.1 billion, just shy of the $13.23 billion projected by industry analysts. The Walt Disney Company (NYSE:DIS) belongs to Services sector. Its net profit margin is 15.80% and weekly performance is 2.73%. On last trading day company shares ended up $121.69. The Walt Disney Company (NYSE:DIS) distance from 50-day simple moving average (SMA50) is 6.59%.

Netflix Inc., (NASDAQ:NFLX) the company that places no limits on vacation, is taking its time-off policy a step further by offering unlimited parental leave. Netflix, Inc. (NASDAQ:NFLX) shares advanced 7.63% in last trading session and ended the day at $121.15. NFLX Gross Margin is 32.30% and its return on assets is 2.40%. Netflix, Inc. (NASDAQ:NFLX) quarterly performance is 49.95%.

Alibaba Group Holding Ltd (NYSE:BABA) named former Goldman Sachs Group partner Michael Evans as president, putting him in charge of the e-commerce company’s global expansion beyond its home in China. On 04 August, Alibaba Group Holding Ltd (NYSE:BABA) shares advanced 1.13% and was closed at $78.87. BABA EPS growth in last 5 year was 101.50%. Alibaba Group Holding Ltd (NYSE:BABA) year to date (YTD) performance is -24.12%.

A Tesla Motors Inc. (NASDAQ:TSLA) executive called on rival automakers to put more compelling electric vehicles on the road and said fuel-efficiency standards should be far more stringent. Tesla Motors Inc (NASDAQ:TSLA) ended the last trading day at $266.28. Company weekly volatility is calculated as 2.54% and price to cash ratio as 22.29. Tesla Motors Inc (NASDAQ:TSLA) showed a weekly performance of 0.55%.

Baxalta Incorporated (NYSE: BXLT), announced the publication of pivotal phase III data for BAX 111 in Blood, the journal of the American Society of Hematology. The data showed that 100 percent of the patients treated with BAX 111, a highly purified recombinant von Willebrand factor (rVWF) candidate, achieved success in the management of bleeding episodes.2 BAX 111 is currently under review by the U.S. Food and Drug Administration (FDA).Baxalta Incorporated (NYSE:BXLT) shares advanced 11.92% in last trading session and ended the day at $37.10.

Leave a Reply

Your email address will not be published. Required fields are marked *